- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech High Growth Potential Companies
U.K. Pharmaceuticals & Biotech High Growth Potential Companies
Results
6
Companies with a Future performance score of at least 3, ordered by Future performance score.
6 companies
Shield Therapeutics
Market Cap: UK£113.6m
A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.
STX
UK£0.11
7D
1.9%
1Y
300.0%
Oxford Biomedica
Market Cap: UK£726.8m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£6.03
7D
-6.4%
1Y
42.4%
hVIVO
Market Cap: UK£44.9m
Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.
HVO
UK£0.066
7D
37.5%
1Y
-68.2%
Diaceutics
Market Cap: UK£118.0m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.39
7D
-2.5%
1Y
16.3%
Genus
Market Cap: UK£1.7b
Produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia.
GNS
UK£25.50
7D
-2.7%
1Y
56.4%
AstraZeneca
Market Cap: UK£211.1b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£136.12
7D
0.3%
1Y
29.3%